Nextremity Solutions Gains FDA Clearance For Lapidus Procedure

By Julie A. Vetalice

Nextremity Solutions received FDA 510(k) clearance to market the InCore™ Lapidus system for fusion of the first tarsometatarsal joint.

InCore Lapidus is a three-part construct intended for internal fixation for First Metatarsocuneiform Arthrodesis. An application is pending for CE Mark approval.

Source: Nextremity Solutions, Inc.

Product Labels: Trauma Ankle/Foot/Toe

Tags: 510(k) Clearance, Regulatory